Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Sedona Sweeney

Assistant Professor
in Health Economics

Room
327

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
020 7927 2890
Jump to: Affiliations Teaching Research Publications

Sedona has nine years’ experience in economic evaluation in low- and middle-income countries. Her research focuses on the improving understanding of the economic impact of substantial long-term health shocks, both at the provider level and within the household. Her research to date has been focused on measurement and understanding of the costs of chronic illness – including HIV, TB, chronic non-communicable diseases, and HCV.

She is a member of the Task Force on Catastrophic Cost Measurement for TB, and is a co-investigator of the Value-TB project; a Bill and Melinda Gates funded multi-country costing study of TB interventions. She is also involved with the Global Health Costing Consortium, in which she focuses on costing standards and methods.

ORCiD

ResearchGate profile

Affiliations
Department of Global Health and Development
Faculty of Public Health and Policy

Centres

Centre for Evaluation
TB Centre

Teaching

Sedona teaches on the Economic Evaluation module for in-house students.  She also supervises HPPF students.

Research

Sedona's current research projects include:

  • VALUE-TB: a collaboration between LSHTM, University of Cape Town, and WHO aiming to collect cost data to facilitate decision-making for TB in five countries (incl. Kenya, Ethiopia, Philippines, India, and Russia)
  • the Global Health Cost Consortium: which aims to mitigate the TB and HIV epidemics by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services
Past involvement in research projects includes:
  • the Integra Initiative: an analysis of integrated HIV and sexual and reproductive health services in Kenya and Swaziland
  • the Health Systems Chronic Disease project: a project aiming to improve the health systems response to chronic disease in Uganda and Tanzania
  • a project assessing the impact and cost-effectiveness of needle/syringe provision on hepatitis C transmission among people who inject drugs in the UK
  • the MERGE project: evaluating a model of scaling-up integrated TB and HIV services in South Africa
Research Area
Economic evaluation
Health systems
Sexual health
Social and structural determinants of health
Equity
Randomised controlled trials
Violence
Discipline
Health economics
Economics
Disease and Health Conditions
Cardiovascular disease
Chronic disease
HIV/AIDS
Sexually transmitted disease
Tuberculosis
Syphilis
Diabetes
Hepatitis
Non-communicable diseases
Country
China
Ethiopia
United Kingdom
India
Kenya
Philippines
Swaziland
Tanzania
Uganda
South Africa
Region
East Asia & Pacific (developing only)
Europe & Central Asia (all income levels)
Least developed countries: UN classification
Sub-Saharan Africa (developing only)

Selected Publications
A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
Cunnama L; Gomez GB; Siapka M; Herzel B; Hill J; Kairu A; Levin C; Okello D; DeCormier Plosky W; Garcia Baena I
2020
PharmacoEconomics
The impact of Coronavirus disease 2019 (COVID-19) on health systems and household resources in Africa and South Asia
Davies NG; Sweeney S; Torres-Rueda S; Bozzani F; Kitson N; Barasa E; Procter S; Quaife M; Eggo RM; Vassall A
2020
MedRxiv
Commentary on Hancock et al. (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugs.
Platt L; Harris M; Sweeney S
2020
Addiction
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic.
Quaife M; Houben RMGJ; Allwood B; Cohen T; Coussens AK; Harries AD; van Kampen S; Marx FM; Sweeney S; Wallis RS
2020
The Lancet Respiratory Medicine
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression.
Siapka M; Vassall A; Cunnama L; Pineda C; Cerecero D; Sweeney S; Bautista-Arredondo S; Bollinger L; Cameron D; Levin C
2020
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
Sweeney S; Gomez G; Kitson N; Sinha A; Yatskevich N; Staples S; Moodliar R; Motlhako S; Maloma M; Rassool M
2020
BMJ open
Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa.
Sweeney S; Vassall A; Guinness L; Siapka M; Chimbindi N; Mudzengi D; Gomez GB
2020
PharmacoEconomics
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries
Vassall A; Sweeney S; Barasa E; Prinja S; Keogh-Brown MR; Tarp Jensen H; Smith R; Baltussen R; M Eggo R; Jit M
2020
Wellcome Open Research
See more Publications

Contact

Room
327

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
020 7927 2890